Zevra Therapeutics

Zevra Therapeutics

Targeting improved therapies for pain, ADHD and other CNS indications.

Launch date
Employees
Market cap
€363m
Enterprise valuation
€372m (Public information from Sep 2024)
Kissimmee Florida (HQ), Coralville Iowa (founding location)
Authorizing premium user...